NCT02650336View on ClinicalTrials.gov

Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial

CompletedOBSERVATIONAL
Enrollment

592

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Contrast Induced Nephropathy
Interventions
DRUG

contrast

a substance used to enhance the contrast of structures or fluids within the body in medical imaging. It is commonly used to enhance the visibility of blood vessels and the gastrointestinal tract

Trial Locations (1)

510080

Xiaodong Zhaung, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT02650336 - Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial | Biotech Hunter | Biotech Hunter